Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq | Zendy

Ola Ali Nassr | Zendy; Paul Forsyth | Zendy; Chris Johnson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq

Author(s) -

Ola Ali Nassr,

Paul Forsyth,

Chris Johnson

Publication year - 2019

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2019.1.1372

Subject(s) - medicine , acute coronary syndrome , dosing , unstable angina , myocardial infarction , medical prescription , observational study , retrospective cohort study , aspirin , emergency medicine , pharmacology

Approximately one in two patients received the recommended secondary prevention therapy. However, only a minority of patients were prescribed optimal doses of ACEI/ARBs and beta-blockers, in line with guidance. Quality improvement strategies should be implemented, which may include greater involvement of pharmacists within the cardiology multidisciplinary team.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research